Analytical Testing
SPECIAL FEATURE - Artificial Intelligence in Drug Discovery, Development & Delivery
Contributor Cindy H. Dubin speaks with leading drug makers, device manufacturers, and contract organizations who dispel the myths around AI and Machine Learning in the pharma industry and share how they are using AI to streamline clinical trials, automate lab tests, optimize resource allocation, enhance development timelines, and improve patient-friendly dosage forms.
LEADERSHIP PANEL - Trends to Watch for in 2026
Contributor Cindy H. Dubin interviews life science leaders to discuss the role of AI in drug repurposing, the future of personalized medicine, the importance of sustainability, and how to keep pace with innovation amid real-time FDA reviews.
Copley Scientific Launches New Platform for Inhaled Product Testing
The innovative Inhaled Dissolution Apparatus (IDA) from Copley Scientific introduces discriminating dissolution testing to the commercially available in vitro toolkit for inhaled drug products. Addressing a…
Proveris Joins Investindustrial to Support Customers & Long-Term Growth
Proveris Scientific, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced that it has been acquired…
iXCells Biotechnologies Appoints Steve Smith as CEO
iXCells Biotechnologies recently announced the appointment of Steve Smith as CEO. Previously CCO, Steve will lead the Company to advance execution and delivery of iXCells’…
2026 COMPANY PROFILES & CAPABILITIES
For each participating company, this section presents a detailed summary highlighting their core technologies, capabilities, technologies, and services.
2025 Analytical Testing e-Book - New ICH Guideline Outlines E&L Principles
In this exclusive Drug Development & Delivery e-book, Stevanato Group discusses E&L from the perspective of lyophilized products, common E&L testing challenges, how to mitigate testing risks.
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
HERCULES, Calif. Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of…
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Salt Lake City, UT, Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio’s…
Veranova Devens Site Breaks Ground on ADC Facility Expansion
Devens, MA, USA — Government officials, industry leaders, and local business representatives gathered yesterday to mark the groundbreaking of Veranova’s latest expansion at its Devens,…
Synfini Inc. and O2nix Bio Announce Strategic Collaboration to Develop Novel Cancer Therapeutics Targeting FTSJ1
MENLO PARK, Calif. and CAMBRIDGE, Mass.,Synfini Inc., a leader in AI-driven drug discovery, and O2nix Bio, a pioneering biotech company advancing prooxidant therapies, today announced…
Sanner has officially launched manufacturing operations in Greensboro, North Carolina
The new facility is dedicated to producing critical injection-molded components for medical devices and pharmaceutical packaging, as well as desiccant solutions. This expansion reflects Sanner’s…
SPECIAL FEATURE- Outsourcing Formulation Development & Manufacturing: CDMOs Are Making Their Supply Chains More Resilient & Secure
Contributor Cindy H. Dubin speaks with many CDMO professionals to get their insights and perspectives on the current state of the industry.
AccuStem Sciences Signs Agreement to Access Blood Samples From Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
AccuStem Sciences, Inc.recently announced a development agreement to access blood samples from the multi-institutional, prospective, randomized Rete Italiana di Screening Polmonare (RISP) clinical trial. This…
SPECIAL FEATURE - Analytical Testing – Diverse Demands & Therapies Require Diverse Analyses
Contributor Cindy H. Dubin highlights how analytical testing has evolved to address diverse pharmaceutical therapeutics in research and development.
2025 COMPANY PROFILES & CAPABILITIES
For each participating company, this section presents a detailed summary highlighting their core technologies, capabilities, technologies, and services.
EXECUTIVE INTERVIEW - Lonza: Utilizing Analytical Tools & Predictive Models to De-Risk Drug Development
Drug Development & Delivery recently interviewed Josh Marsh, Bioavailability Enhancement and PBPK Lead Scientist at Lonza, to discuss the benefits of predictive tools and Lonza’s approach.
SGS Announces Expansion of Biopharmaceutical Testing Capabilities
SGS recently announced it has added new capacity and capabilities at its center of excellence in Lincolnshire, IL. This expansion adds new instrumentation and expertise…
LGM Pharma Expands Analytical Testing Services With New Endotoxin & Rapid Sterility Testing Capabilities
LGM Pharma recently announced today expansion of its Analytical Testing Services (ATS) with the addition of endotoxin and rapid sterility testing capabilities. These new services,…
SGS Announces Expansion of Biopharmaceutical Testing Capabilities
SGS recently announced it has added new capacity and capabilities at its center of excellence in Lincolnshire, IL. This expansion adds new instrumentation and expertise…
Frequently Asked Questions About Analytical Testing
What are the latest trends in analytical testing for pharmaceuticals?
How are CDMOs improving resilience in analytical supply chains?
What role does automation play in modern analytical labs?
